×

Glucose or ketone body analyte monitoring in vivo

  • US 10,108,781 B2
  • Filed: 09/27/2013
  • Issued: 10/23/2018
  • Est. Priority Date: 09/28/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method comprising:

  • repeatedly receiving, with a processor of an analyte monitoring device, in vivo derived analyte measurements of an analyte, wherein the analyte is glucose or a ketone body;

    calculating, with the processor, an initial analyte trend as level or non-level based on a rate-of-change for a current analyte measurement of the analyte measurements and at least one past analyte measurement of the analyte measurements, wherein the initial analyte trend is level when the rate-of-change is zero or within a predetermined tolerance range for zero; and

    determining, with the processor, whether a final analyte trend for display via a user interface is level or non-level, wherein the final analyte trend determination is based on the initial analyte trend and whether a change-resistant state is active;

    wherein when the change-resistant state is active, a minimum threshold of change is required between the current analyte measurement and a past analyte measurement of the analyte measurements selected as a reference for the final analyte trend to be determined as non-level when a previous final analyte trend was determined to be level;

    wherein the change-resistant state is activated when the final analyte trend is determined to be level and deactivated when the final analyte trend is determined to be non-level; and

    wherein the minimum threshold of change varies based on the current analyte measurement.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×